Core One Labs Inc (COOL.CX)
0.185
0.00 (0.00%)
CAD |
CNSX |
May 17, 16:00
Core One Labs Enterprise Value: 8.808M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | 8.808M |
May 16, 2024 | 8.808M |
May 15, 2024 | 9.515M |
May 14, 2024 | 9.279M |
May 13, 2024 | 9.750M |
May 10, 2024 | 9.986M |
May 09, 2024 | 9.986M |
May 08, 2024 | 10.46M |
May 07, 2024 | 10.22M |
May 06, 2024 | 8.808M |
May 03, 2024 | 10.93M |
May 02, 2024 | 10.93M |
May 01, 2024 | 10.93M |
April 30, 2024 | 10.93M |
April 29, 2024 | 9.279M |
April 26, 2024 | 9.044M |
April 25, 2024 | 8.573M |
April 24, 2024 | 8.573M |
April 23, 2024 | 8.573M |
April 22, 2024 | 9.515M |
April 19, 2024 | 11.16M |
April 18, 2024 | 9.279M |
April 17, 2024 | 9.279M |
April 16, 2024 | 9.750M |
April 15, 2024 | 9.750M |
Date | Value |
---|---|
April 12, 2024 | 9.750M |
April 11, 2024 | 9.750M |
April 10, 2024 | 9.986M |
April 09, 2024 | 9.986M |
April 08, 2024 | 11.40M |
April 05, 2024 | 11.40M |
April 04, 2024 | 9.750M |
April 03, 2024 | 10.93M |
April 02, 2024 | 10.22M |
April 01, 2024 | 9.279M |
March 28, 2024 | 9.044M |
March 27, 2024 | 10.93M |
March 26, 2024 | 10.93M |
March 25, 2024 | 8.808M |
March 22, 2024 | 8.808M |
March 21, 2024 | 8.808M |
March 20, 2024 | 8.808M |
March 19, 2024 | 10.46M |
March 18, 2024 | 11.40M |
March 15, 2024 | 11.40M |
March 14, 2024 | 10.46M |
March 13, 2024 | 10.46M |
March 12, 2024 | 11.40M |
March 11, 2024 | 11.40M |
March 08, 2024 | 10.69M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.640M
Minimum
Jun 04 2020
138.69M
Maximum
Feb 10 2021
27.62M
Average
18.03M
Median
Feb 07 2022
Enterprise Value Benchmarks
Biocure Technology Inc | 1.448M |
Nova Mentis Life Science Corp | 2.183M |
Nanosphere Health Sciences Inc | 0.2445M |
Lobe Sciences Ltd | 3.658M |
Algernon Pharmaceuticals Inc | -- |
Enterprise Value Related Metrics
Net Income (Quarterly) | -0.8407M |
Revenue (Quarterly) | 0.0937M |
Total Expenses (Quarterly) | 0.5213M |
EPS Diluted (Quarterly) | -0.02 |
Profit Margin (Quarterly) | -897.6% |
Earnings Yield | -54.05% |
Normalized Earnings Yield | -39.35 |